Literature DB >> 23397951

Mutations of the BRAF gene in human cancer, by Davies et al. (Nature 2002; 417: 949-54).

G W M Millington1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23397951     DOI： 10.1111/ced.12015

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  17 in total

1.  Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.

Authors:  Kun Huang; Ningning Gao; Donglin Bian; Qixi Zhai; Puxu Yang; Yunfei Zhang
Journal:  Exp Ther Med       Date:  2020-10-22       Impact factor: 2.447

2.  Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown.

Authors:  Pu Zhang; Shan Feng; Gentao Liu; Heyong Wang; Huifeng Zhu; Qiao Ren; Huiyuan Bai; Changliang Fu; Cheng Dong
Journal:  J Biol Chem       Date:  2015-10-26       Impact factor: 5.157

3.  Diagnostic value of puncture feeling combined with BRAF V600E mutation in repeat US-FNA biopsy of Bethesda III thyroid nodules.

Authors:  Li Li; Peipei Li; Xiao Chen; Lin Kang; Yuquan Ye
Journal:  Gland Surg       Date:  2021-06

Review 4.  Oncolytic virus immunotherapy for melanoma.

Authors:  Neal Dharmadhikari; Janice M Mehnert; Howard L Kaufman
Journal:  Curr Treat Options Oncol       Date:  2015-03

5.  Evaluation of the Anyplex BRAF V600E real-time detection assay using dual-priming oligonucleotide technology in fine-needle aspirates of thyroid nodules.

Authors:  Rihwa Choi; Kyung Sun Park; Jong Won Kim; Chang Seok Ki
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

Review 6.  Immune system and melanoma biology: a balance between immunosurveillance and immune escape.

Authors:  Anna Passarelli; Francesco Mannavola; Luigia Stefania Stucci; Marco Tucci; Francesco Silvestris
Journal:  Oncotarget       Date:  2017-10-31

7.  Upregulated LAMB3 increases proliferation and metastasis in thyroid cancer.

Authors:  Yinghao Wang; Yixiang Jin; Adheesh Bhandari; Zhihan Yao; Fan Yang; Yiyuan Pan; Zhouci Zheng; Shixu Lv; Ouchen Wang
Journal:  Onco Targets Ther       Date:  2017-12-21       Impact factor: 4.147

8.  MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701.

Authors:  Chia-Hung Chen; Te-Chun Hsia; Ming-Hsin Yeh; Tsung-Wei Chen; Yun-Ju Chen; Jung-Tsu Chen; Ya-Ling Wei; Chih-Yen Tu; Wei-Chien Huang
Journal:  Mol Oncol       Date:  2017-07-19       Impact factor: 6.603

9.  Identification of 2R-ohnologue gene families displaying the same mutation-load skew in multiple cancers.

Authors:  Michele Tinti; Kumara Dissanayake; Silvia Synowsky; Luca Albergante; Carol MacKintosh
Journal:  Open Biol       Date:  2014-05-07       Impact factor: 6.411

10.  Different effection of p.1125Val>Ala and rs11954856 in APC on Wnt signaling pathway.

Authors:  Fei-Feng Li; Zhi-Xun Zhao; Peng Yan; Song Wang; Zheng Liu; Qiong Zhang; Xiao-Ning Zhang; Chang-Hao Sun; Xi-Shan Wang; Gui-Yu Wang; Shu-Lin Liu
Journal:  Oncotarget       Date:  2017-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.